These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children. Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209 [No Abstract] [Full Text] [Related]
6. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine. Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868 [No Abstract] [Full Text] [Related]
7. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells. Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858 [No Abstract] [Full Text] [Related]
8. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus. Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511 [No Abstract] [Full Text] [Related]
9. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus. Takaku K; Sasada T; Konobe T; Onishi K; Ueda S Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510 [No Abstract] [Full Text] [Related]
11. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region]. Arrouji A; Mirchamsy H; Marnissi A Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563 [No Abstract] [Full Text] [Related]
12. Comparative study on two further attenuated live measles virus vaccines, "CAM" and "Moraten". Sangkawibha N; Tuchinda P; Bukkavesa S; Osatanonda P; Ueda S Biken J; 1971 Mar; 14(1):77-9. PubMed ID: 5090682 [No Abstract] [Full Text] [Related]
13. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile]. Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374 [No Abstract] [Full Text] [Related]
14. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine]. Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095 [No Abstract] [Full Text] [Related]
15. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths]. Böttiger M; Heller L; Kamensky P; Svanberg B Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083 [No Abstract] [Full Text] [Related]
17. [Epidemiological control of smallpox virus in Ecudor]. Gutierrez Vera E Rev Ecuat Hig Med Trop; 1976; 29():13-24. PubMed ID: 189361 [No Abstract] [Full Text] [Related]
18. Studies on further attenuated liver measles vaccine. VI. Clinical and serological follow-up one year after vaccination. Ueda S; Takahashi M; Kurimura T; Suzuki N; Yamanishi K Biken J; 1971 Sep; 14(3):247-51. PubMed ID: 4258008 [No Abstract] [Full Text] [Related]
19. [Vaccination against measles]. Cocchi P; Corti R Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156 [TBL] [Abstract][Full Text] [Related]
20. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]